Consun Pharmaceutical Group Limited (01681) Announces Monthly Return on Movements in Securities

Bulletin Express02-02 17:08

Consun Pharmaceutical Group Limited (01681) published its monthly return for the period ended 31 January 2026. The total authorised share capital remained at 5,000,000,000 ordinary shares (HKD 0.1 par value), amounting to HKD 500,000,000. The number of issued shares recorded a net decrease of 6,985,296, bringing the total from 848,493,407 down to 841,508,111.

According to the filing, 1,399,704 new ordinary shares were issued through the exercise of share options under a scheme approved on 2 December 2013, raising HKD 5,650,256.88. Additionally, 8,385,000 shares were redeemed and cancelled, with a further 100,000 shares redeemed but not yet cancelled as of the end of the reporting period. Public float requirements continued to be met at the prescribed 25% threshold.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1197168666?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-02 17:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1197168666","market":"hk","top_or_hot":-1,"title":"Consun Pharmaceutical Group Limited (01681) Announces Monthly Return on Movements in Securities","media":"Bulletin Express","content":"<p>Consun Pharmaceutical Group Limited (01681) published its monthly return for the period ended 31 January 2026. The total authorised share capital remained at 5,000,000,000 ordinary shares (HKD 0.1 par value), amounting to HKD 500,000,000. The number of issued shares recorded a net decrease of 6,985,296, bringing the total from 848,493,407 down to 841,508,111.</p>\n<p>According to the filing, 1,399,704 new ordinary shares were issued through the exercise of share options under a scheme approved on 2 December 2013, raising HKD 5,650,256.88. Additionally, 8,385,000 shares were redeemed and cancelled, with a further 100,000 shares redeemed but not yet cancelled as of the end of the reporting period. Public float requirements continued to be met at the prescribed 25% threshold.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Consun Pharmaceutical Group Limited (01681) Announces Monthly Return on Movements in Securities</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nConsun Pharmaceutical Group Limited (01681) Announces Monthly Return on Movements in Securities\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-02-02 17:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Consun Pharmaceutical Group Limited (01681) published its monthly return for the period ended 31 January 2026. The total authorised share capital remained at 5,000,000,000 ordinary shares (HKD 0.1 par value), amounting to HKD 500,000,000. The number of issued shares recorded a net decrease of 6,985,296, bringing the total from 848,493,407 down to 841,508,111.</p>\n<p>According to the filing, 1,399,704 new ordinary shares were issued through the exercise of share options under a scheme approved on 2 December 2013, raising HKD 5,650,256.88. Additionally, 8,385,000 shares were redeemed and cancelled, with a further 100,000 shares redeemed but not yet cancelled as of the end of the reporting period. Public float requirements continued to be met at the prescribed 25% threshold.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01681","symbol_name":"康臣药业","start_time":0,"source_url":"","article_id":"1197168666","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1197168666","pubTimestamp":1770023296,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Consun Pharmaceutical Group Limited (01681) published its monthly return for the period ended 31 January 2026. The total authorised share capital remained at 5,000,000,000 ordinary shares (HKD 0.1...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01681":"康臣药业"},"translate_title":"康臣药业集团有限公司(01681)公布证券变动月报表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01681":1},"content_text":"Consun Pharmaceutical Group Limited (01681) published its monthly return for the period ended 31 January 2026. The total authorised share capital remained at 5,000,000,000 ordinary shares (HKD 0.1 par value), amounting to HKD 500,000,000. The number of issued shares recorded a net decrease of 6,985,296, bringing the total from 848,493,407 down to 841,508,111.\nAccording to the filing, 1,399,704 new ordinary shares were issued through the exercise of share options under a scheme approved on 2 December 2013, raising HKD 5,650,256.88. Additionally, 8,385,000 shares were redeemed and cancelled, with a further 100,000 shares redeemed but not yet cancelled as of the end of the reporting period. Public float requirements continued to be met at the prescribed 25% threshold.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1197168666","isCrawlerRequest":true}